United States will impose steep tariffs on generic drugs starting twenty twenty-eight. President Donald Trump announced the policy change through his active social media account.
For two years, zero percent tariffs will continue for all imported generic medicines.
After that period, tariffs increase to one hundred percent for an additional year. Eventually, the tariff rate will climb further, reaching two hundred percent later.
The decision aims to encourage domestic production and penalize non-investing pharmaceutical companies. Pharmaceutical industry and importers are now assessing the possible impacts and consequences.
